Search - tctmd.com

Displaying 1 - 20 of 167

Sort: Relevancy | Date

Presentation TCT 2025

TCT 487: Percutaneous Coronary Intervention with Drug-Coated Balloons in de novo Lesions in Patients with Diabetes Mellitus: A Real-World Experience

Presenter: Victor Alfonso Jimenez Diaz

October 28, 2025

Presentation TCT 2025

Supraflex Cruz versus Xience in Patients with Diabetes and Multivessel Coronary Artery Disease Undergoing Percutaneous Coronary Intervention: Results from the TUXEDO-2 Randomized Trial

Presenter: Upendra Kaul

October 28, 2025

Presentation TCT 2025

TCT 498: Comparative Effectiveness of GLP-1 Receptor Agonists vs. SGLT2 Inhibitors on Cardiovascular Outcomes in Patients with Diabetes Undergoing Percutaneous Coronary Intervention

Presenter: Ahmed A. Mahmoud

October 28, 2025

Presentation TCT 2025

TCT 496: Type 2 Diabetes Is Linked to More Severe Coronary Artery Disease on Cardiac Computed Tomography Angiography but Not to More Invasive Treatment: Insights from a Propensity-Matched Study

Presenter: WIllem Robert van de Vijver

October 28, 2025

Presentation TCT 2025

TCT 494: Cost-Effectiveness of SGLT2 Inhibitors, Statins, and GLP-1 Receptor Agonists for Cardiovascular Secondary Prevention: A Comparative Analysis

Presenter: Mehmet Cilingiroglu

October 28, 2025

Presentation TCT 2025

TCT 499: Impact of GLP-1 Agonists on Cardiovascular Outcomes in Obese Adults with HFrEF receiving Guideline Directed Medical Therapy: A Propensity Score Matched Analysis

Presenter: Dawood Shehzad

October 28, 2025

Presentation TCT 2025

TCT 497: Combined Assessment of Lipoprotein(a) and Non-Culprit Coronary LesionSeverity on Clinical Outcomes in Acute Coronary Syndrome

Presenter: Hirokazu Tanaka

October 28, 2025

Presentation TCT 2025

TCT 493: Tailored Antiplatelet Therapy in High-Risk Diabetic Patients Undergoing Complex Percutaneous Coronary Intervention: The Prespecified Analysis of TAILORED-CHIP Trial

Presenter: Seong-Bong Wee

October 28, 2025

Presentation TCT 2025

TCT 489: Socioeconomic Disparities in the Prevalence of Modified Metabolic Syndrome in the United States using National Health and Nutrition Examination Survey 2017–2023 Data

Presenter: Sangho Hyun

October 28, 2025

Presentation TCT 2025

TCT 491: Impact of Proprotein Convertase Subtilisin/Kexin Type 9 Inhibition on Platelet Reactivity in Patients with Atherosclerotic Cardiovascular Disease: A Pooled Analysis of Two Randomized Double-blind Placebo-controlled studies

Presenter: Claudio Laudani

October 28, 2025

Presentation TCT 2025

TCT 492: Sodium-Glucose Co-Transporter 2 Inhibitors on Cardiovascular Outcomes Post-PCI in Patients with Diabetes: Findings from the TriNetX Database

Presenter: Aymen Ahmed

October 28, 2025

Presentation TCT 2025

TCT 488: Sex-Based Differences in Cardiovascular Outcomes With Achieved LDL-C <55 mg/dL: A Comparative Cohort Analysis

Presenter: Mehmet Cilingiroglu

October 28, 2025

Presentation TCT 2025

TCT 288: The Diabetes Effect: Mortality Risk Persists in Cardiogenic Shock STEMI Despite Contemporary PCI

Presenter: Miles Chapman

October 27, 2025

Presentation TCT 2025

TCT 1003: Clinical Effectiveness of Glucagon-like peptide-1 receptor agonists on Cardiovascular outcomes Post-PCI in Type 2 Diabetes patients: Findings from the TriNetX Database

Presenter: Aymen Ahmed

October 27, 2025

Presentation TCT 2025

TCT 1283: Clinical Presentation and Long-Term Outcomes of Patients Without Standard Modifiable Cardiovascular Risk Ffactors: Insight from the DECADE Cooperation

Presenter: Claudio Laudani

October 27, 2025

Presentation TCT 2025

TCT 483: SIroliMus-coated Balloon-based PCI versus DES-onLy PCI in patiEnts with DiabetES Mellitus: The SIMPLE-DM Individual Patient Data analysis

Presenter: Mauro Gitto

October 27, 2025

Presentation TCT 2025

TCT 484: Artificial Intelligence for prediction of Amputations in Diabetic Foot Ulcers: A Systematic Review and Meta-analysis

Presenter: Rahul Ravindra

October 27, 2025

Presentation TCT 2025

TCT 482: Regular Supervised Exercise Training Improves Endothelial Function, Early Atherosclerosis, Arterial Stiffness and Endothelial Progenitor Cells in PCI Patients.

Presenter: Jae Hyoung Park

October 27, 2025

Presentation TCT 2025

TCT 486: Lipoprotein(a) as a Predictor of Lesion Complexity in Patients undergoing Elective Percutaneous Coronary Intervention : Insights from an Asian single center cohort

Presenter: Melly Susanti

October 27, 2025

Presentation TCT 2025

TCT 485: Lipoprotein(a) and Long-Term Cardiovascular Events in Patients With Coronary Vasospasm

Presenter: Melly Susanti

October 27, 2025

Advertisement

TCT 487: Percutaneous Coronary Intervention with Drug-Coated Balloons in de novo Lesions in Patients with Diabetes Mellitus: A Real-World Experience

Supraflex Cruz versus Xience in Patients with Diabetes and Multivessel Coronary Artery Disease Undergoing Percutaneous Coronary Intervention: Results from the TUXEDO-2 Randomized Trial

TCT 498: Comparative Effectiveness of GLP-1 Receptor Agonists vs. SGLT2 Inhibitors on Cardiovascular Outcomes in Patients with Diabetes Undergoing Percutaneous Coronary Intervention

TCT 496: Type 2 Diabetes Is Linked to More Severe Coronary Artery Disease on Cardiac Computed Tomography Angiography but Not to More Invasive Treatment: Insights from a Propensity-Matched Study

TCT 494: Cost-Effectiveness of SGLT2 Inhibitors, Statins, and GLP-1 Receptor Agonists for Cardiovascular Secondary Prevention: A Comparative Analysis

TCT 499: Impact of GLP-1 Agonists on Cardiovascular Outcomes in Obese Adults with HFrEF receiving Guideline Directed Medical Therapy: A Propensity Score Matched Analysis

TCT 497: Combined Assessment of Lipoprotein(a) and Non-Culprit Coronary LesionSeverity on Clinical Outcomes in Acute Coronary Syndrome

TCT 493: Tailored Antiplatelet Therapy in High-Risk Diabetic Patients Undergoing Complex Percutaneous Coronary Intervention: The Prespecified Analysis of TAILORED-CHIP Trial

TCT 489: Socioeconomic Disparities in the Prevalence of Modified Metabolic Syndrome in the United States using National Health and Nutrition Examination Survey 2017–2023 Data

TCT 491: Impact of Proprotein Convertase Subtilisin/Kexin Type 9 Inhibition on Platelet Reactivity in Patients with Atherosclerotic Cardiovascular Disease: A Pooled Analysis of Two Randomized Double-blind Placebo-controlled studies

TCT 492: Sodium-Glucose Co-Transporter 2 Inhibitors on Cardiovascular Outcomes Post-PCI in Patients with Diabetes: Findings from the TriNetX Database

TCT 488: Sex-Based Differences in Cardiovascular Outcomes With Achieved LDL-C <55 mg/dL: A Comparative Cohort Analysis

TCT 288: The Diabetes Effect: Mortality Risk Persists in Cardiogenic Shock STEMI Despite Contemporary PCI

TCT 1003: Clinical Effectiveness of Glucagon-like peptide-1 receptor agonists on Cardiovascular outcomes Post-PCI in Type 2 Diabetes patients: Findings from the TriNetX Database

TCT 1283: Clinical Presentation and Long-Term Outcomes of Patients Without Standard Modifiable Cardiovascular Risk Ffactors: Insight from the DECADE Cooperation

TCT 483: SIroliMus-coated Balloon-based PCI versus DES-onLy PCI in patiEnts with DiabetES Mellitus: The SIMPLE-DM Individual Patient Data analysis

TCT 484: Artificial Intelligence for prediction of Amputations in Diabetic Foot Ulcers: A Systematic Review and Meta-analysis

TCT 482: Regular Supervised Exercise Training Improves Endothelial Function, Early Atherosclerosis, Arterial Stiffness and Endothelial Progenitor Cells in PCI Patients.

TCT 486: Lipoprotein(a) as a Predictor of Lesion Complexity in Patients undergoing Elective Percutaneous Coronary Intervention : Insights from an Asian single center cohort

TCT 485: Lipoprotein(a) and Long-Term Cardiovascular Events in Patients With Coronary Vasospasm

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content